Witzeman Michael D 4
4 · CHEMED CORP · Filed Aug 1, 2024
Insider Transaction Report
Form 4
CHEMED CORPCHE
Witzeman Michael D
VP & Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy with tandem tax withholding)
2024-07-31$471.74/sh−7,948$3,749,390→ 29,885 totalExercise: $471.74Exp: 2025-10-29→ Capital Stock (7,948 underlying) - Tax Payment
Capital Stock
2024-07-31$560.99/sh−7,225$4,053,153→ 3,784 total - Exercise/Conversion
Capital Stock
2024-07-31$471.74/sh+7,948$3,749,390→ 11,009 total
Footnotes (2)
- [F1]Payment of purchase price and tax obligation on stock option exercise.
- [F2]Vesting in three equal annual installments commencing 10/29/2021